PARIS: A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including dementia and cardiovascular diseases, although experts warned against seeing them as miracle drugs.The study published in Nature Medicine is unique in its scope, marking a milestone in the study of new-generation weight-loss drugs such … Read more
 "Biden wants to make weight-loss drugs more accessible. Will it pass the Trump test? – Firstpost")
Good news awaits millions of Americans suffering from obesity and desperate to shed the kilos. The Biden administration has announced a proposal to require Medicare and Medicaid to cover weight-loss drugs. The Health and Human Services (HHS) Department unveiled the proposal on Tuesday to add anti-obesity drugs like Wegovy, Zepbound, Ozempic and Mounjaro under Medicare … Read more
 "Can weight-loss drugs Ozempic and Wegovy cause blindness? – Firstpost")
The world has long been concerned about obesity. It has long been known for its connections to non-communicable diseases like diabetes, cardiovascular disease, and hypertension. Initially presented as a simple fix for this issue, Ozempic and Wegovy quickly gained popularity as weight loss choices, even among Hollywood celebrities. A new study published on Wednesday in the … Read more
 "Why is it so difficult to lose weight? ‘Fat cells’ may be the reason – Firstpost")
Losing weight is a challenging process, but keeping it off can be even more difficult. Researchers have been investigating why this happens, and they may have found the answer. Studies suggest that even after weight loss, fat cells retain a “memory” of obesity. This finding explains why maintaining weight loss can be so tough. The … Read more
About 44% of U.S. employers with 500 or more employees cover drugs for weight loss in 2024, up from 41% in 2023, according to a survey from consulting firm Mercer released on Wednesday. Mercer also said 64% of U.S. employers with over 20,000 employees covered weight-loss drugs in 2024, compared with 56% last year. That … Read more
SHANGHAI, China — Novo Nordisk is facing the prospect of intensifying competition in the promising Chinese market, where drugmakers are developing at least 15 generic versions of its diabetes drug Ozempic and weight loss treatment Wegovy, clinical trial records showed. The Danish drugmaker has high hopes that demand for its blockbuster drugs will surge in … Read more
At 17, Israel McKenzie was so burdened by obesity that he stopped going to high school in person and was embarrassed to speak to people at his restaurant job. “I was in a really dark place,” said McKenzie, whose weight had climbed to 335 pounds on his 6-foot-1-inch frame, despite repeated efforts to diet and … Read more
Novo Nordisk, the company behind Ozempic and Wegovy, published a new analysis of the longest study it has conducted so far through the lens of long-term weight loss. The 17,604-person study, published in Nature Medicine and presented at the European Congress on Obesity in Venice, Italy on Tuesday, showed for the first time that obesity … Read more
A recent Pew Research Center study found that most Americans don’t think that new injectable weight loss drugs like Ozempic will do much to help obesity in the U.S. About 42 percent of adults in the U.S. are obese, according to the CDC. 65 percent of Americans don’t think willpower alone is enough to lose … Read more
